The Effect of AyuFlex® Supplementation on Joint Health

Status Completed

Clinical Trial Summary

The purpose of this 12-week, prospective study is to determine the effects of oral supplementation with AyuFlex® (an over-the-counter dietary supplement) on joint mobility, joint comfort and functional capacity in healthy overweight subjects.

Clinical Trial Description

This interventional study is a 12-week, randomized, double-blind, placebo and dose-response controlled clinical trial (in 3 parallel groups) of male and female subjects without active osteoarthritis of the knee to be recruited at a single investigational center in the U.S. A two-week placebo lead-in period will precede the study to enhance statistical power. One-hundred and five (105) overweight, apparently healthy subjects, pre-screened using health history questionnaires, vital signs, blood work and a standardized lower extremity exercise performance test will be randomized to one of three groups for 84 days: placebo, AyuFlex1 (500 mg/d) or AyuFlex2 (1000 mg/d). AyuFlex is an organic, non-GMO, over-the-counter joint health product derived from the edible fruits of Terminalia chebula. ;

Study Design

Related Conditions & MeSH terms

Arthralgia

Clinical Trial Details

NCT number	NCT02589249
Study type	Interventional
Source	The Center for Applied Health Sciences, LLC
Contact
Status	Completed
Phase	N/A
Start date	November 2015
Completion date	February 7, 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03802578` - The Impact of Exercise on Hand Function, Daily Activities Performance and Quality of Life of SLE' Patients	N/A
Completed	`NCT01896050` - Loss of Grip Strength, BMI, and Adjuvant Endocrine Therapy Breast Cancer	N/A
Recruiting	`NCT04354649` - Immune-Mediated Pathophysiology And Clinical Triage Program	Phase 2
Terminated	`NCT00973141` - A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related Pain	Phase 2
Recruiting	`NCT05564182` - High Intensity Laser Therapy in the Treatment of Hemiplegic Shoulder Pain	N/A
Recruiting	`NCT05033613` - Home Blood Pressure Monitoring Before and After COVID-19 Vaccination in Patients at High Risk of Cardiovascular Disease
Recruiting	`NCT03953157` - Dietary and Exercise Interventions in Reducing Side Effects in Patients With Stage I-IIIa Breast Cancer Receiving Aromatase Inhibitors	N/A
Terminated	`NCT02947022` - Effects of IV-Administered Ca-DTPA and Zn-DTPA To Treat Patients With Gadolinium Deposition Disease	Phase 1/Phase 2
Terminated	`NCT02047851` - Randomized, Blinded, Sham-controlled Trial of Acupuncture for the Management of Joint Pain in Patients With Psoriasis	N/A
Withdrawn	`NCT01612728` - Treatment for Joint Pains Due to Aromatase Inhibitor Therapy in Breast Cancer	Phase 2
Completed	`NCT02118636` - Observational Study to Evaluate Mechanisms of Aromatase Inhibitor Associated Musculoskeletal Symptoms	N/A
Completed	`NCT00416715` - Vitamin D Deficiency, Muscle Pain, Joint Pain, and Joint Stiffness in Postmenopausal Women Receiving Letrozole For Stage I-III Breast Cancer	Phase 2
Completed	`NCT00361582` - A Study to Evaluate the Effectiveness and Safety of Multiple Doses of Tapentadol(CG5503) in Patients Awaiting Joint Replacement Surgery	Phase 3
Completed	`NCT02831582` - Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast Cancer	N/A
Recruiting	`NCT04494412` - An Intravenous (IV) Zanamivir Pharmacokinetics (PK) Study in Hospitalized Neonates and Infants With Influenza Infection	Phase 2
Not yet recruiting	`NCT06134050` - Finding the Optimal Aim of Correction in Opening Wedge High Tibial Osteotomy	N/A
Completed	`NCT02778906` - Abatacept Reversing Subclinical Inflammation as Measured by MRI in ACPA Positive Arthralgia	Phase 3
Terminated	`NCT01096407` - Role of Biomarkers in Muscle Pain and Joint Pain in Patients With Solid Tumors Receiving Paclitaxel	Phase 1
Terminated	`NCT04164563` - Even-Up to Minimize Secondary Site Pain For Ankle Fracture	N/A
Completed	`NCT04161833` - Opera® for Aromatase Inhibitor-related Arthralgia Management (AIA)	N/A